WO1998052616A3 - Nichtsteroidale antirheumatika oder thrombozytenaggregationshemmer zur verbesserung der gefäss-, lymphknoten- und knochenmarkdarstellung mit pharmazeutischen zubereitungen, die partikel, vesikel oder polymere enthalten - Google Patents
Nichtsteroidale antirheumatika oder thrombozytenaggregationshemmer zur verbesserung der gefäss-, lymphknoten- und knochenmarkdarstellung mit pharmazeutischen zubereitungen, die partikel, vesikel oder polymere enthalten Download PDFInfo
- Publication number
- WO1998052616A3 WO1998052616A3 PCT/DE1998/001288 DE9801288W WO9852616A3 WO 1998052616 A3 WO1998052616 A3 WO 1998052616A3 DE 9801288 W DE9801288 W DE 9801288W WO 9852616 A3 WO9852616 A3 WO 9852616A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- thrombocyte
- lymph nodes
- vesicles
- polymers
- agglutination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU83313/98A AU8331398A (en) | 1997-05-21 | 1998-05-04 | Nonsteroidal antirheumatic agents or thrombocyte-agglutination inhibitors to improve representation of vessels, lymph nodes and bone marrow with pharmaceutical preparations containing particles, vesicles of polymers |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19721947.0 | 1997-05-21 | ||
DE1997121947 DE19721947C2 (de) | 1997-05-21 | 1997-05-21 | Verwendung von pharmazeutischen Zubereitungen, die Partikel, Vesikel oder Polymere sowie nichtsteroidale Antirheumatika und/oder Thrombozytenaggregationshemmer zur Darstellung der Gefäße, Lymphknoten und des Knochenmarks enthalten |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1998052616A2 WO1998052616A2 (de) | 1998-11-26 |
WO1998052616A3 true WO1998052616A3 (de) | 1999-04-01 |
Family
ID=7830513
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DE1998/001288 WO1998052616A2 (de) | 1997-05-21 | 1998-05-04 | Nichtsteroidale antirheumatika oder thrombozytenaggregationshemmer zur verbesserung der gefäss-, lymphknoten- und knochenmarkdarstellung mit pharmazeutischen zubereitungen, die partikel, vesikel oder polymere enthalten |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU8331398A (de) |
DE (1) | DE19721947C2 (de) |
WO (1) | WO1998052616A2 (de) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9380998B2 (en) | 1998-12-24 | 2016-07-05 | Devicor Medical Products, Inc. | Subcutaneous cavity marking device and method |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6371904B1 (en) | 1998-12-24 | 2002-04-16 | Vivant Medical, Inc. | Subcutaneous cavity marking device and method |
US9669113B1 (en) | 1998-12-24 | 2017-06-06 | Devicor Medical Products, Inc. | Device and method for safe location and marking of a biopsy cavity |
DE102007006693A1 (de) | 2007-02-12 | 2008-08-21 | Adc Gmbh | Überspannunsschutzmagazin |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2350102A1 (fr) * | 1976-05-05 | 1977-12-02 | Beecham Group Ltd | Composition pharmaceutique analgesique |
EP0307087A1 (de) * | 1987-08-05 | 1989-03-15 | Alliance Pharmaceutical Corp. | Emulsionen von Fluorkohlenwasserstoffen für "in vivo"-Verwendung |
US5391376A (en) * | 1991-11-12 | 1995-02-21 | Long, Jr.; David M. | Method for preventing and treating cachexia |
WO1995010306A1 (en) * | 1993-10-15 | 1995-04-20 | Alliance Pharmaceutical Corp. | Prophylaxis in the parenteral administration of particulate dispersions |
WO1996009840A1 (en) * | 1994-09-27 | 1996-04-04 | Nycomed Imaging A/S | Contrast agent |
WO1996035429A1 (de) * | 1995-05-10 | 1996-11-14 | Schering Aktiengesellschaft | Verwendung nichtsteroidaler entzündungshemmer zur verbesserung der physiologischen verträglichkeit partikulärer pharmazeutischer zubereitungen |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU598002B2 (en) * | 1986-07-15 | 1990-06-14 | Cilag Ltd. | Method of preparing single bilayered liposomes |
JPH0827030A (ja) * | 1994-07-08 | 1996-01-30 | Terumo Corp | 腎臓を認識する薬物担体 |
US5573783A (en) * | 1995-02-13 | 1996-11-12 | Nano Systems L.L.C. | Redispersible nanoparticulate film matrices with protective overcoats |
-
1997
- 1997-05-21 DE DE1997121947 patent/DE19721947C2/de not_active Expired - Lifetime
-
1998
- 1998-05-04 AU AU83313/98A patent/AU8331398A/en not_active Abandoned
- 1998-05-04 WO PCT/DE1998/001288 patent/WO1998052616A2/de active Search and Examination
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2350102A1 (fr) * | 1976-05-05 | 1977-12-02 | Beecham Group Ltd | Composition pharmaceutique analgesique |
EP0307087A1 (de) * | 1987-08-05 | 1989-03-15 | Alliance Pharmaceutical Corp. | Emulsionen von Fluorkohlenwasserstoffen für "in vivo"-Verwendung |
US5391376A (en) * | 1991-11-12 | 1995-02-21 | Long, Jr.; David M. | Method for preventing and treating cachexia |
WO1995010306A1 (en) * | 1993-10-15 | 1995-04-20 | Alliance Pharmaceutical Corp. | Prophylaxis in the parenteral administration of particulate dispersions |
WO1996009840A1 (en) * | 1994-09-27 | 1996-04-04 | Nycomed Imaging A/S | Contrast agent |
WO1996035429A1 (de) * | 1995-05-10 | 1996-11-14 | Schering Aktiengesellschaft | Verwendung nichtsteroidaler entzündungshemmer zur verbesserung der physiologischen verträglichkeit partikulärer pharmazeutischer zubereitungen |
Non-Patent Citations (6)
Title |
---|
AUERBACH M ET AL: "Clinical use of the total dose intravenous infusion of iron dextran.", J LAB CLIN MED, MAI 1988, VOL. 111, NO. 5, PAGE(S) 566-70, XP002091828 * |
CHEMICAL ABSTRACTS, vol. 129, Columbus, Ohio, US; abstract no. 92312, KRESSE, M. ET AL: "IV Iron oxides as contrast agents in magnetic resonance lymphography" XP002091830 * |
FUTURE STRATEGIES DRUG DELIVERY PART. SYST., LECT. EUR. WORKSHOP PART. SYST., 1ST, MEETING DATE 1997, PAGES 63-69. EDITOR(S): DIEDERICHS, JULI E.;MUELLER, RAINER H. PUBLISHER: MEDPHARM SCIENTIFIC PUBLISHERS, STUTTGART, GERMANY. * |
POLETTE, A. ET AL: "Effect of vitamin E on acute iron load-potentiated aggregation, secretion calcium uptake and thromboxane biosynthesis in rat platelets", ATHEROSCLEROSIS, VOL. 96, NO. 2-3, PAGE(S) 171-9, 1992, XP002091826 * |
SCHAFFER, BRADLEY K. ET AL: "MION-ASF: biokinetics of an MR receptor agent", MAGN. RESON. IMAGING, VOL. 11, NO. 3, PAGE(S) 411-17, 1993, XP002091827 * |
SIDI Y. ET AL: "Platelet aggregation and adhesiveness in severe iron deficiency due to menorrhage", NEW ISTANBUL CONTRIBUTION TO CLINICAL SCIENCE, VOL. 12, NO. 2, PAGE(S) 161-165, 1978, XP002091829 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9380998B2 (en) | 1998-12-24 | 2016-07-05 | Devicor Medical Products, Inc. | Subcutaneous cavity marking device and method |
Also Published As
Publication number | Publication date |
---|---|
DE19721947C2 (de) | 1999-04-22 |
DE19721947A1 (de) | 1998-11-26 |
WO1998052616A2 (de) | 1998-11-26 |
AU8331398A (en) | 1998-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Gold et al. | Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion. | |
NO980002L (no) | Kaskadepolymerkomplekser, fremgangsmåte for fremstilling, samt farmasöytiske midler inneholdende disse | |
DE59510531D1 (de) | Behältnis zur Lagerung und Verabreichung von Injektions-, Infusions- und Diagnostikpräparaten | |
ES2102007T3 (es) | Proteinas de fusion de fragmentos de anticuerpo monomeras y dimeras. | |
DE69535684D1 (de) | Zusammensetzungen welche DNA zerstoerende Agentien und P53 enthalten | |
FR2730930B1 (fr) | Utilisation d'inhibiteurs de no-synthase pour diminuer l'effet irritant cutane de produits utilises dans le domaine cosmetique ou pharmaceutique | |
DE69421943D1 (de) | Kontrastmittel | |
ATE424418T1 (de) | Kohlenhydratbindungsdomäne enthaltende fusionsproteine zur verabreichung von therapeutischen und anderen stoffen und zusammensetzungen in denen die fusionsproteine enthalten sind | |
DE69635671D1 (de) | Verwendung von roxithromycin zur herstellung eines medikaments zur verbesserung der biologischen und antiviralen aktivität von protease-inhibitoren | |
ES2130428T3 (es) | Cristales de insulina asp-b28. | |
AU6933900A (en) | Method, reagent and test cartridge for determining clotting time | |
WO1998052616A3 (de) | Nichtsteroidale antirheumatika oder thrombozytenaggregationshemmer zur verbesserung der gefäss-, lymphknoten- und knochenmarkdarstellung mit pharmazeutischen zubereitungen, die partikel, vesikel oder polymere enthalten | |
DE59814134D1 (de) | Interaktionssystem zur präsentation und entfernung von substanzen | |
EP0924523A3 (de) | Verfahren und Diagnosemittel zum Nachweis von Hämostasestörungen | |
DE69914537D1 (de) | Derivate von Bicyclo[2.2.1]heptan, Verfahren zu ihrer Herstellung und deren Verwendung als Antreibflüssigkeit | |
ES2117670T3 (es) | Derivado de hidroxamato e hidrazida de poliaminas y su uso medico como agentes quelantes. | |
EP1304123A3 (de) | Verfahren zur Modulierung des Wachstums kollateraler Arterien und / oder anderer Arterien aus bestehenden arteriolen Verbindungen | |
Virca et al. | Quantitation of human leukocyte elastase, cathepsin G, α-2-macro-globulin and α-1-proteinase inhibitor in osteoarthrosis and rheumatoid arthritis synovial fluids | |
NO953638L (no) | Gass-genererende kontrastmidler | |
ID22416A (id) | Komposisi-komposisi farmasi yang mengandung ibuprofen dan domperidon untuk pengobatan migrain | |
DE69841573D1 (de) | Verfahren zur erhöhung der magnesiumabsorption und verhinderung von artheriosklerose | |
DE3889279D1 (de) | Diagnostisches Mittel und Verfahren zur Bestimmung von Apolipoprotein B. | |
FR2825928B1 (fr) | Composition pharmaceutique pour le diagnostic, la prevention ou le traitement d'une pathologie tumorale, comprenant un agent modulateur de l'etat polymerisation de l'actine | |
WO2001063294A3 (en) | Diagnosis of bipolar affective disorder (bad) and unipolar depression | |
Hunter et al. | The effect of poloxamer 188 on the rate of in vitro thrombolysis mediated by t-PA and streptokinase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU CA CN HU JP KR NO US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU CA CN HU JP KR NO US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: JP Ref document number: 1998549789 Format of ref document f/p: F |
|
NENP | Non-entry into the national phase |
Ref country code: CA |